Amanote Research
Register
Sign In
Pgi41 - Clinical Characteristics of Biologic Treated Crohn’s Disease Patients With and Without Prior Surgery in European Union
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.883
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
C. Karki
Y. Lu
N. Sharma
H. Triggs
Publisher
Elsevier BV
Related search
Safety Profile of Biologic Therapy in Polish Paediatric Patients With Crohn’s Disease
Przeglad Gastroenterologiczny
Gastroenterology
Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?
Digestive Diseases and Sciences
Physiology
Gastroenterology
Surgery and Crohn’s Disease
Pss59 - Clinical Characteristics of Biologic Eligible Hidradenitis Suppurativa Patients in Eu5
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Characterizing Unmet Medical Need and the Potential Role of New Biologic Treatment Options in Patients With Ulcerative Colitis and Crohn’s Disease
European Journal of Gastroenterology and Hepatology
Hepatology
Gastroenterology
Prevalence of Comorbidites Among Patients With Psoriasis (Pso) With and Without Psoriatic Arthritis (Psa) in European Union (Eu)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Fulminant Legionellosis in Two Patients Treated With Infliximab for Crohn’s Disease: Case Series and Literature Review
Canadian Journal of Gastroenterology
Clinical Characteristics of Chronic Otolaryngeal Patients Treated With Kampo Medicines
Kampo Medicine
